Clinical Trials - STOK

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06872125A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet SyndromeRECRUITINGPHASE32025-06-042027-082027-03
NCT04740476An Open-Label Extension Study of STK-001 for Patients With Dravet SyndromeENROLLING_BY_INVITATIONPHASE22021-01-202027-03-032026-02-03
NCT04442295An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet SyndromeCOMPLETEDPHASE1, PHASE22020-06-292023-11-142023-11-14